Deka Bank Deutsche Girozentrale Reata Pharmaceuticals Inc Transaction History

Deka Bank Deutsche Girozentrale

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	SELL	$30.85 - $93.17 $173,994 - $525,478	-5,640 Reduced 24.91%	17,000 $1.51 Million
Q2 2022 Aug 03, 2022	BUY	$20.71 - $36.5 $124,260 - $219,000	6,000 Added 36.06%	22,640 $710,000
Q1 2022 Apr 28, 2022	BUY	$24.12 - $39.6 $36,180 - $59,400	1,500 Added 9.91%	16,640 $514,000
Q4 2021 Feb 02, 2022	BUY	$25.61 - $110.96 $10,244 - $44,384	400 Added 2.71%	15,140 $357,000
Q4 2020 Mar 12, 2021	SELL	$102.03 - $184.62 $4.66 Million - $8.43 Million	-45,650 Reduced 75.59%	14,740 $1.89 Million
Q3 2020 Oct 29, 2020	BUY	$93.53 - $163.34 $4.99 Million - $8.72 Million	53,390 Added 762.71%	60,390 $5.56 Million
Q2 2020 Aug 04, 2020	SELL	$126.3 - $176.56 $227,340 - $317,808	-1,800 Reduced 20.45%	7,000 $1.06 Million
Q1 2020 May 14, 2020	BUY	$124.16 - $247.74 $161,408 - $322,062	1,300 Added 17.33%	8,800 $1.28 Million
Q4 2019 Feb 04, 2020	BUY	$74.57 - $217.92 $559,275 - $1.63 Million	7,500 New	7,500 $1.58 Million
Q3 2019 Nov 14, 2019	SELL	$71.26 - $95.75 $3.23 Million - $4.34 Million	-45,300 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$77.72 - $94.35 $2.95 Million - $3.58 Million	37,900 Added 512.16%	45,300 $4.15 Million
Q1 2019 May 10, 2019	SELL	$51.9 - $101.79 $791,475 - $1.55 Million	-15,250 Reduced 67.33%	7,400 $639,000
Q4 2018 Feb 12, 2019	BUY	$48.76 - $76.44 $743,590 - $1.17 Million	15,250 Added 206.08%	22,650 $1.18 Million
Q3 2018 Nov 09, 2018	SELL	$35.64 - $92.06 $7,128 - $18,412	-200 Reduced 2.63%	7,400 $0
Q1 2018 May 03, 2018	BUY	$20.0 - $30.19 $152,000 - $229,444	7,600 New	7,600 $152,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.